All news

Edwards Lifesciences leads five analyst upgrades

Alpha Vantage · Benzinga · · AI-summarised by FinFlash

Wall Street analysts upgraded five companies, led by Edwards Lifesciences (NYSE: EW), raised to Buy from Hold with a price target lifted to

Read original source

EW company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.